[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

NCT01633255 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Kidney Neoplasms

Interventions

DRUG: 18F-Fluciclatide

Sponsor

National Cancer Institute (NCI)